"10.1371_journal.pone.0045559","plos one","2012-09-19T00:00:00Z","Simone Buraschi; Thomas Neill; Rick T Owens; Leonardo A Iniguez; George Purkins; Rajanikanth Vadigepalli; Barry Evans; Liliana Schaefer; Stephen C Peiper; Zi-Xuan Wang; Renato V Iozzo","Department of Pathology, Anatomy and Cell Biology, and the Cancer Cell Biology and Signaling Program, Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania, United States of America; LifeCell Corporation, Branchburg, New Jersey, United States of America; Roche NimbleGen, Inc., Research and Development, Madison, Wisconsin, United States of America; Department of Pharmacology, Goethe University, Frankfurt, Germany","Conceived and designed the experiments: RVI SB TN. Performed the experiments: SB TN. Analyzed the data: RVI SB TN GP RV BE LS Z-XW. Contributed reagents/materials/analysis tools: RTO LAI SCP Z-XW. Wrote the paper: RVI SB TN.","RTO works for LifeCell Co. and has provided the recombinant decorin used for the studies. LAI works for Roche-NibleGen Co. and has provided expertise in performing the microarray data. There are no patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2012","09","Simone Buraschi","SB",11,TRUE,3,2,8,3,TRUE,TRUE,FALSE,0,NA,FALSE
